These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 26512963)
21. The STAT3 Inhibitor Galiellalactone Effectively Reduces Tumor Growth and Metastatic Spread in an Orthotopic Xenograft Mouse Model of Prostate Cancer. Canesin G; Evans-Axelsson S; Hellsten R; Sterner O; Krzyzanowska A; Andersson T; Bjartell A Eur Urol; 2016 Mar; 69(3):400-4. PubMed ID: 26144873 [TBL] [Abstract][Full Text] [Related]
22. The mechanism of DAB2IP in chemoresistance of prostate cancer cells. Wu K; Xie D; Zou Y; Zhang T; Pong RC; Xiao G; Fazli L; Gleave M; He D; Boothman DA; Hsieh JT Clin Cancer Res; 2013 Sep; 19(17):4740-9. PubMed ID: 23838317 [TBL] [Abstract][Full Text] [Related]
23. Pretreatment biopsy analysis of DAB2IP identifies subpopulation of high-risk prostate cancer patients with worse survival following radiation therapy. Jacobs C; Tumati V; Kapur P; Yan J; Xie XJ; Hannan R; Hsieh JT; Kim DW; Saha D Cancer Med; 2015 Dec; 4(12):1844-52. PubMed ID: 26471467 [TBL] [Abstract][Full Text] [Related]
24. The prostaglandin E2 receptor, EP2, regulates survivin expression via an EGFR/STAT3 pathway in UVB-exposed mouse skin. Chun KS; Langenbach R Mol Carcinog; 2011 Jun; 50(6):439-48. PubMed ID: 21268125 [TBL] [Abstract][Full Text] [Related]
25. EZH2-regulated DAB2IP is a medulloblastoma tumor suppressor and a positive marker for survival. Smits M; van Rijn S; Hulleman E; Biesmans D; van Vuurden DG; Kool M; Haberler C; Aronica E; Vandertop WP; Noske DP; Würdinger T Clin Cancer Res; 2012 Aug; 18(15):4048-58. PubMed ID: 22696229 [TBL] [Abstract][Full Text] [Related]
26. 2'-hydroxyflavanone inhibits prostate tumor growth through inactivation of AKT/STAT3 signaling and induction of cell apoptosis. Wu K; Ning Z; Zhou J; Wang B; Fan J; Zhu J; Gao Y; Wang X; Hsieh JT; He D Oncol Rep; 2014 Jul; 32(1):131-8. PubMed ID: 24859932 [TBL] [Abstract][Full Text] [Related]
27. Docetaxel-mediated autophagy promotes chemoresistance in castration-resistant prostate cancer cells by inhibiting STAT3. Hu F; Zhao Y; Yu Y; Fang JM; Cui R; Liu ZQ; Guo XL; Xu Q Cancer Lett; 2018 Mar; 416():24-30. PubMed ID: 29246644 [TBL] [Abstract][Full Text] [Related]
28. Cyclin-dependent kinase 5 modulates STAT3 and androgen receptor activation through phosphorylation of Ser⁷²⁷ on STAT3 in prostate cancer cells. Hsu FN; Chen MC; Lin KC; Peng YT; Li PC; Lin E; Chiang MC; Hsieh JT; Lin H Am J Physiol Endocrinol Metab; 2013 Oct; 305(8):E975-86. PubMed ID: 23941877 [TBL] [Abstract][Full Text] [Related]
29. KLF9, a transcription factor induced in flutamide-caused cell apoptosis, inhibits AKT activation and suppresses tumor growth of prostate cancer cells. Shen P; Sun J; Xu G; Zhang L; Yang Z; Xia S; Wang Y; Liu Y; Shi G Prostate; 2014 Jun; 74(9):946-58. PubMed ID: 24737412 [TBL] [Abstract][Full Text] [Related]
30. Absence of DAB2IP promotes cancer stem cell like signatures and indicates poor survival outcome in colorectal cancer. Min J; Liu L; Li X; Jiang J; Wang J; Zhang B; Cao D; Yu D; Tao D; Hu J; Gong J; Xie D Sci Rep; 2015 Nov; 5():16578. PubMed ID: 26564738 [TBL] [Abstract][Full Text] [Related]
31. The ATM inhibitor KU55933 sensitizes radioresistant bladder cancer cells with DAB2IP gene defect. Zhang T; Shen Y; Chen Y; Hsieh JT; Kong Z Int J Radiat Biol; 2015 Apr; 91(4):368-78. PubMed ID: 25585815 [TBL] [Abstract][Full Text] [Related]
32. The role of TXNDC5 in castration-resistant prostate cancer-involvement of androgen receptor signaling pathway. Wang L; Song G; Chang X; Tan W; Pan J; Zhu X; Liu Z; Qi M; Yu J; Han B Oncogene; 2015 Sep; 34(36):4735-45. PubMed ID: 25500540 [TBL] [Abstract][Full Text] [Related]
33. Numb Guo Y; Zhang K; Cheng C; Ji Z; Wang X; Wang M; Chu M; Tang DG; Zhu HH; Gao WQ Clin Cancer Res; 2017 Nov; 23(21):6744-6756. PubMed ID: 28751447 [No Abstract] [Full Text] [Related]
34. c-Jun NH(2)-terminal kinase mediates leptin-stimulated androgen-independent prostate cancer cell proliferation via signal transducer and activator of transcription 3 and Akt. Miyazaki T; Bub JD; Iwamoto Y Biochim Biophys Acta; 2008 Oct; 1782(10):593-604. PubMed ID: 18718531 [TBL] [Abstract][Full Text] [Related]
35. Increased Hsp27 after androgen ablation facilitates androgen-independent progression in prostate cancer via signal transducers and activators of transcription 3-mediated suppression of apoptosis. Rocchi P; Beraldi E; Ettinger S; Fazli L; Vessella RL; Nelson C; Gleave M Cancer Res; 2005 Dec; 65(23):11083-93. PubMed ID: 16322258 [TBL] [Abstract][Full Text] [Related]
36. Signal transducer and activator of transcription-3 drives the high-fat diet-associated prostate cancer growth. Kwan HY; Liu B; Huang C; Fatima S; Su T; Zhao X; Ho AHM; Han Q; Hu X; Gong RH; Chen M; Wong HLX; Bian Z Cell Death Dis; 2019 Sep; 10(9):637. PubMed ID: 31474764 [TBL] [Abstract][Full Text] [Related]
37. ACSL4 promotes prostate cancer growth, invasion and hormonal resistance. Wu X; Deng F; Li Y; Daniels G; Du X; Ren Q; Wang J; Wang LH; Yang Y; Zhang V; Zhang D; Ye F; Melamed J; Monaco ME; Lee P Oncotarget; 2015 Dec; 6(42):44849-63. PubMed ID: 26636648 [TBL] [Abstract][Full Text] [Related]
38. Smurf1 regulation of DAB2IP controls cell proliferation and migration. Li X; Dai X; Wan L; Inuzuka H; Sun L; North BJ Oncotarget; 2016 May; 7(18):26057-69. PubMed ID: 27036023 [TBL] [Abstract][Full Text] [Related]
39. Differential regulation of the human gene DAB2IP in normal and malignant prostatic epithelia: cloning and characterization. Chen H; Pong RC; Wang Z; Hsieh JT Genomics; 2002 Apr; 79(4):573-81. PubMed ID: 11944990 [TBL] [Abstract][Full Text] [Related]
40. DAB2IP-knocking down resulted in radio-resistance of breast cancer cells is associated with increased hypoxia and vasculogenic mimicry formation. Zhang X; Wang Q; Zhang R; Kong Z Int J Radiat Biol; 2023; 99(10):1595-1606. PubMed ID: 36947637 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]